CAS 2070015-00-6

Formule : C26H29F4N5O6S

InChI : InChI=1S/C19H21F4N5O3.C7H8O3S/c1-3-24-16-12(19(21,22)23)10-25-18(27-16)26-14-9-13(20)11(8-15(14)30-2)17(29)28-4-6-31-7-5-28;1-6-2-4-7(5-3-6)11(8,9)10/h8-10H,3-7H2,1-2H3,(H2,24,25,26,27);2-5H,1H3,(H,8,9,10)

Code InChI : VYAOJDYMEMFZKS-UHFFFAOYSA-N

SMILES : CCNC1=NC(=NC=C1C(F)(F)F)NC2=C(C=C(C(=C2)F)C(=O)N3CCOCC3)OC.CC1=CC=C(C=C1)S(=O)(=O)O

GNE-7915 (tosylate)

CAS : 2070015-00-6

GNE-7915 (tosylate)

Formule : C₂₆H₂₉F₄N₅O₆S

Degré de pureté : 99.69%

Masse moléculaire : 615.6

Ref: 54-PC1031391

GNE-7915 (tosylate)

CAS : 2070015-00-6

Formule : C₂₆H₂₉F₄N₅O₆S

Degré de pureté : 99.69%

Masse moléculaire : 615.597

Ref: IN-DA01EOQC

GNE-7915 tosylate

CAS : 2070015-00-6

GNE-7915 tosylate is a potent, selective, and brain-penetrant LRRK2 inhibitor, boasting an IC50 value of 9 nM.

Formule : C₂₆H₂₉F₄N₅O₆S

Couleur et forme : Solid

Masse moléculaire : 615.597

Ref: TM-T72640

Gne-7915 tosylate

CAS : 2070015-00-6

GNE-7915 tosylate is an investigational small molecule inhibitor, which is chemically synthesized, designed to target specific kinases involved in cancer pathways. As a product of rigorous medicinal chemistry, it is derived from sophisticated laboratory synthesis processes utilizing advanced chemical techniques aimed at optimizing specificity and potency.

Formule : C₂₆H₂₉F₄N₅O₆S

Degré de pureté : Min. 95%

Masse moléculaire : 615.6 g/mol

Ref: 3D-VHD01500